Gentherm Incorporated Stock

Equities

THRM

US37253A1034

Auto, Truck & Motorcycle Parts

Market Closed - Nasdaq 04:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
50.74 USD +0.67% Intraday chart for Gentherm Incorporated -0.63% -3.09%
Sales 2024 * 1.55B Sales 2025 * 1.68B Capitalization 1.59B
Net income 2024 * 84M Net income 2025 * 112M EV / Sales 2024 * 1.06 x
Net Debt 2024 * 50.64M Net Debt 2025 * 23.96M EV / Sales 2025 * 0.96 x
P/E ratio 2024 *
19.1 x
P/E ratio 2025 *
14.5 x
Employees 14,504
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.69%
More Fundamentals * Assessed data
Dynamic Chart
JPMorgan Adjusts Gentherm's Price Target to $60 From $63, Keeps Underweight Rating MT
Carrar Ltd. announced that it has received $5.3 million in funding from Salida B.V., OurCrowd Ltd., Next Gear Ventures, Gentherm Incorporated, NextLeap Ventures, Dive Digital Gmbh, and other investors CI
Gentherm Insider Sold Shares Worth $827,621, According to a Recent SEC Filing MT
Gentherm Insider Sold Shares Worth $845,948, According to a Recent SEC Filing MT
Baird Adjusts Price Target on Gentherm to $66 From $60, Maintains Neutral Rating MT
Tranche Update on Gentherm Incorporated's Equity Buyback Plan announced on December 18, 2020. CI
Transcript : Gentherm Incorporated, Q4 2023 Earnings Call, Feb 21, 2024
Gentherm's Q4 Adjusted Earnings, Revenue Increase MT
Earnings Flash (THRM) GENTHERM Reports Q4 Revenue $366.9M, vs. Street Est of $358.3M MT
Earnings Flash (THRM) GENTHERM Posts Q4 EPS $0.90, vs. Street Est of $0.52 MT
Gentherm Incorporated Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Gentherm Incorporated Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Gentherm Incorporated Provides Earnings Guidance for the Full Year 2024 and the Year 2026 CI
JPMorgan Trims Gentherm Price Target to $58 From $59, Maintains Underweight Rating MT
Gentherm, SourceMark Medical Expand Partnership on Patient Temperature Management Products MT
More news
1 day+0.67%
1 week-0.63%
Current month-11.88%
1 month-7.71%
3 months+4.45%
6 months-2.31%
Current year-3.09%
More quotes
1 week
49.13
Extreme 49.1301
51.17
1 month
49.13
Extreme 49.1301
57.96
Current year
46.51
Extreme 46.505
62.93
1 year
38.21
Extreme 38.205
66.54
3 years
38.21
Extreme 38.205
99.00
5 years
27.24
Extreme 27.24
99.00
10 years
26.60
Extreme 26.6
99.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 17-12-03
Director of Finance/CFO 52 18-12-31
Chief Tech/Sci/R&D Officer 41 23-09-04
Members of the board TitleAgeSince
Director/Board Member 60 20-08-10
Chairman 65 16-05-25
Director/Board Member 54 Nov. 30
More insiders
Date Price Change Volume
24-04-24 50.74 +0.67% 118,760
24-04-23 50.4 +1.14% 128,596
24-04-22 49.83 -0.32% 121,186
24-04-19 49.99 -0.46% 152,887
24-04-18 50.22 -0.52% 137,394

Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT

More quotes
Gentherm Incorporated is a provider of thermal management and pneumatic comfort technologies for the automotive industry and medical industries. The Company operates through two segments: Automotive and Medical. The Automotive segment represents the design, development, manufacturing and sales of automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronic and software systems. Its automotive electronic and software systems include electronic control units for climate comfort systems, electronic control units. Its climate comfort systems include seat heaters, blowers, and thermoelectric devices. The Medical segment is comprised of the results from the patient temperature management business in the medical industry. The Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
50.4 USD
Average target price
69 USD
Spread / Average Target
+36.90%
Consensus